-
Male birth control: Will the future ever arrive?
Nick Merrill Medical & Allied HealthcareFlying cars are the perennial example of a technology from the future that we may never see come to light. Seemingly just as impossible of a pipe dream is male birth control. How is that possible? Here is a look at some of the most promising methods of male birth control, the amazing science behind them and where they are in development.
-
The challenging market environment for drug companies
Mike Wokasch PharmaceuticalThe traditional pharmaceutical industry is going through perhaps its biggest transformation since The Pure Food and Drug Act of 1906. Unfortunately, the entrenched "we have always done it this way" leadership mentality has been slow to react to the magnitude of changes taking place over the past two decades.
-
Zohydro ER: Who are we really here for?
Jason Poquette PharmaceuticalHealthcare is supposed to be about helping sick people, but sometimes I think we have forgotten who we really serve. For example, there has been no shortage of criticism over the FDA decision to approve Zohydro ER back in October.
-
A link between blood and plasma trace metals in Alzheimer’s disease?
Dr. Afsaneh Motamed-Khorasani Medical & Allied HealthcareAlzheimer's disease (AD) is the most common type of dementia in the elderly, with a rapidly increasing prevalence. In the past three decades, we have witnessed remarkable advances in our understanding of AD, both in terms of the disease course and its symptoms.
-
Improving daily health communication with patients
Cynthia Sheppard Solomon PharmaceuticalWe do a lot of "live" activities in our daily encounters with patients — evaluating lab results, health screens, potential drug interactions. Afterward, we often speak with the patient to reinforce how he or she currently views expectations and possible side effects of prescribed medicines. Each of these activities provides a heightened level of safety to our patients. So are we doing a good job these days?
-
The rising threat of heroin: Part II
Lauren Swan Mental HealthcareFor the past several weeks, Philip Seymour Hoffman has been in the headlines for his recent overdose on heroin that resulted in his death. His name has become a top search term on Google, and is the first suggestion after you type the letter "P."
-
Prescription drug overdose – Can we be honest?
Jason Poquette PharmaceuticalWaste Management & EnvironmentalSome topics tend to generate more heat than light, and prescription drug overdose is one of them. Type in the word “addiction” or “overdose” into any news search engine, and you will quickly have a list of articles longer than the half-life of methadone to manage. And this isn’t surprising. The number of deaths attributed to drug overdose in America is climbing.
-
The rising threat of heroin: Part I
Lauren Swan Law Enforcement, Defense & SecurityAddiction to opioids is growing at an alarming rate, with the number of addicts practically doubling from 2007 to 2012. Of the opioids, heroin use is increasing the quickest; and after 10 years of continuous growth, it's becoming a noticeable problem.
-
Malignant melanoma: Diagnosis and treatment progress
Rosemary Sparacio Medical & Allied HealthcareImmunology has been in the forefront and progress in the area of skin cancer — particularly malignant melanoma — and has shown great promise. Melanoma is the sixth-most common cancer in the U.S., and the most common fatal malignancy in young adults.
-
A look at the latest therapeutic methods for migraine
Dr. Afsaneh Motamed-Khorasani PharmaceuticalMigraine is a common and devastating disorder, with chronic migraine characterized by headaches for more than or equal to 15 days per month. There are several treatment options for this condition, and here is a look at some of the latest developments.
All Pharmaceutical Articles